Abstract:Abstract Skin cancer is the most common cancer worldwide. Early diagnosis is crucial for improving patient survival and morbidity. Artificial intelligence (AI)-assisted smartphone applications (apps) for skin cancer potentially offer accessible, early risk assessment of suspicious skin lesions. If harnessed to effective and responsive dermatology services, they may improve patient outcomes. The integration of novel technologies into dermatology raises ethical concerns. Ethical principles for acceptable AI governance are well known. Less well elucidated are how these should be applied to actual AI apps. Ethical use-case analysis can improve this understanding. Accordingly, we undertook an ethical use-case analysis of commercially available skin cancer apps. We applied previously described methods for ethical analysis of clinical AI applications to two popular skin cancer apps: SkinVision and Scanoma (Rogers WA, Draper H, Carter SM. Evaluation of artificial intelligence clinical applications: detailed case analyses show value of healthcare ethics approach in identifying patient care issues. Bioethics 2021; 35: 623–33). Systematic searches incorporating published literature, regulatory documents, and websites were undertaken to provide a detailed description of each app, and review the available evidence about their development, effectiveness and use. Screening for inclusion was undertaken by two researchers independently. Ethical concerns were identified with reference to previously described ethical concerns and principles for AI-assisted healthcare. These data were also independently checked and agreed on. By conceptualizing ethical principles within the use context of skin cancer apps, we identified specific ethical issues arising throughout the AI lifecycle of both apps. One company provided extensive detail regarding algorithm development and decision making; this information was insufficiently reported for the other app. Other concerns identified related to the number, quality, consistency and independence of studies assessing algorithm efficacy. Limited efforts to address potential skin tone biases and exclusion of patients with darker skin as target users by one app risk perpetuating existing inequalities. Inadequate regulatory requirements were highlighted. To the best of our knowledge, this study represents the first ethical use-case analysis of patient-facing AI-assisted skin cancer apps. Our findings suggest inadequate incorporation of bioethical norms such as justice, responsibility and transparency into the development and deployment of both apps. Improved regulation will increase accountability. Ensuring ethics by design through integration between technology developers, dermatologists, ethicists and patients is urgently needed to prevent the potential benefits of AI-assisted skin cancer apps being overshadowed by potential ethical harms.

DermIA: Machine Learning to Improve Skin Cancer Screening

Dermo- AI : Skin cancer Identification App using Artificial Intelligence and Machine Learning

Artificial Intelligence Support for Skin Lesion Triage in Primary Care and Dermatology (Preprint)

Artificial Intelligence Support for Skin Lesion Triage in Primary Care and Dermatology

Melanlysis: A Mobile Deep Learning Approach for Early Detection of Skin Cancer

Skin Cancer Diagnostics with an All-Inclusive Smartphone Application

Deep Learning Skin Disease Classifiers: Current Status and Future Prospects

AI in Dermatology: A Systematic Review on Skin Cancer Detection

An artificial intelligence based app for skin cancer detection evaluated in a population based setting

Artificial Intelligence Smartphone Application for Detection of Simulated Skin Changes: An In Vivo Pilot Study

Automatized self-supervised learning for skin lesion screening

Artificial Intelligence in the detection of skin cancer: state of the art

Poster presentationsBT15 Ethical implications of artificial intelligence in dermatology: use-case analysis of skin cancer diagnostic smartphone apps

Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance

Artificial Intelligence and Its Effect on Dermatologists’ Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study

BT09 Clinical performance of an artificial intelligence-based medical device deployed within an urgent suspected skin cancer pathway

Automated Machine Learning (AutoML) for the Diagnosis of Melanoma Skin Lesions From Consumer-Grade Camera Photos

Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by Dermatologists

Early detection of skin cancer using AI: Deciphering dermatology images for melanoma detection

A machine learning‐based, decision support, mobile phone application for diagnosis of common dermatological diseases

Intelligent Dermatologist Tool for Classifying Multiple Skin Cancer Subtypes by Incorporating Manifold Radiomics Features Categories